Serum miRNAs as diagnostic tools in GI malignancies
4 Jul 2016
Serum miRNAs as diagnostic tools in GI malignancies
Combination trial designs: efficient, effective and tolerable regimens
Patient perspectives in precision medicine: 'No innovation about us without us'
Preclinical strategies for precision medicine in colorectal cancer
WIN 2016 highlights: Emerging technologies
Critique of the SHIVA trial
Personalising breast cancer therapy
Affordable next generation sequencing to support decision making
Characterisation of somatic mutations using patient RNASeq profiles
WIN 2016 highlights: Changing the understanding of cancer
Results of the MINDACT clinical trial
Systems thinking in the future of personalised medicine